Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1Benjamin Besse, Manuel Cobo, Céline Mascaux et al.|Annals of Oncology|2023Cited by 69
910O Primary results of the phase III JAVELIN head & neck 100 trial: Avelumab plus chemoradiotherapy (CRT) followed by avelumab maintenance vs CRT in patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN)Ezra E.W. Cohen, N. Lee, Robert L. Ferris et al.|Annals of Oncology|2020Cited by 42